the molecular heterogeneity of acute myeloid leukemia (aml) – new data and implications
Published 7 years ago • 288 plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
2:30
understanding the complexity of acute myeloid leukemia (aml)
-
2:17
understanding the molecular complexity of aml
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
1:21
a new era of treatment for elderly acute myeloid leukemia (aml) patients?
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
6:18
biomarkers for acute myeloid leukemia (aml) – lessons from il-2 immunotherapy with hdc
-
38:34
tracer: antigen-centric mhc recognition by a novel engineered protein platform
-
2:32
how quickly does aml progress? #aml
-
3:16
acute myeloid leukaemia: everything you need to know
-
4:29
unraveling the mysteries of hematologic malignancies: leukemia vs lymphoma
-
3:37
the future of aml treatment
-
1:11
are idh mutations good minimal residual disease (mrd) markers in acute myeloid leukemia (aml)?
-
1:02
the impact of sequencing in aml
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
1:33
updates to the icc classification of aml
-
2:10
single cell sequencing of aml: elucidating clonal heterogeneity
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:43
diagnostic tools for aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml